MoonLake Immunotherapeuti... (MLTX)
NASDAQ: MLTX
· Real-Time Price · USD
53.95
1.41 (2.68%)
At close: Sep 24, 2025, 3:59 PM
54.90
1.77%
After-hours: Sep 24, 2025, 07:33 PM EDT
2.68% (1D)
| Bid | 52 |
| Market Cap | 3.43B |
| Revenue (ttm) | 101.85K |
| Net Income (ttm) | -176.47M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -19.34 |
| Forward PE | -13.61 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 58.66 |
| Volume | 465,385 |
| Avg. Volume (20D) | 574,319 |
| Open | 52.20 |
| Previous Close | 52.54 |
| Day's Range | 52.00 - 54.59 |
| 52-Week Range | 31.42 - 61.87 |
| Beta | 1.27 |
| Ex-Dividend Date | n/a |
About MLTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MLTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MLTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+17.95%
MoonLake Immunotherapeutics shares are trading hig...
Unlock content with
Pro Subscription
3 months ago
+5.51%
MoonLake Immunotherapeutics shares are trading higher following reports that Merck held talks to acquire the Swiss biotech company for over $3 billion.
